Zydus Pharmaceuticals (USA) Inc. Announces FDA Final Approval for the Generic Version of Topamax(R) Tablets

... PRINCETON, N.J., March 27 /PRNewswire/ -- zydus Pharmaceuticals announced today that it has receiv...n for the 12 months ending February 28, 2009. zydus Pharmaceuticals (USA) Inc., located in Princeton, ... presence in over 50 countries worldwide. This is zydus Pharmaceutical's 42nd tentative or final approval ...

Cadila Gets Tentative USFDA Nod For Pravastatin Sodium Tablets

...ths of 10 mg, 20 mg, 40 mg and 80 mg, the company informed the Bombay Stock Exchange. The company would market the drug through its US subsidiary zydus Pharmaceuticals (USA) Inc, following patent expiry, it added. The drug, which had branded sales of approximately 1.8 billion dollars in the US ma...

Cadila gets US FDA approval for Promethazine tablets

... drug is estimated at $116 million. The group had recently received approval to market Ribavirin capsules in the US market through its US subsidiary zydus Pharmaceuticals Inc, it added. ...

Hope for patients with Chronic leukemia

... For the first time in India ,German Remedies, a part of the zydus group, has launched Fludara Oral (fludarabine) for the treatment // of chronic lymphocytic leukemia. Chronic Lymphocytic Leukemia (CLL) is a cancer of...

Nicholas buys ICI’s drug business for Rs 70 c

...or, which will catapult NPIL to the number one position in the Rs 1,300-crore India cardiovascular market. The other players in the segment are Cipla, zydus Cadila, Torrent Pharmaceuticals and Sun Pharmaceuticals. Mr Piramal said, “This acquisition is significant for our presence in high-growth segmen...

Sun Pharma to launch chiral version of omeprazole soon

...ver, any further details as to the price or the brand name were not divulged. In this particular segment, there are three other players, namely zydus Cadila, Dr. Reddy’s Laboratories and Ranbaxy Laboratories. Astra Zeneca, the worldwide patent holder of the molecule omeprazole, has an isomer version...

Zydus Cadila and Kopran in strategic alliance

... The Ahmedabad-based zydus Cadila Healthcare announced a strategic alliance w...igned its anti-hypertensive drug 'Aten'(Atenol) to zydus Cadila for a consideration of Rs. 75 crores but wi... continue to manufacture the drug at its facility, zydus Cadila release said here....

RANBAXY - enters anti-AIDS segment

...S drug segment also witnessed the entry of many more pharmaceutical companies including GlaxoSmithKline Pharmaceuticals, Aurobindo Pharmaceuticals and zydus Cadilla. Recently, the US based Dade Behring diagnostic company renewed its contract with Ranbaxy, putting an end to the guesswork that the US comp...

India's anti-AIDS drug market engaged in price war

...tnessed the entry of four more pharmaceutical companies including Ranbaxy laboratories, GlaxoSmithKline Pharmaceuticals, Aurobindo Pharmaceuticals and zydus Cadila in a short span of six months to one year. The rising competition in the domestic anti-AIDS drug market has led to Cipla, a leader in the se...

Zydus in Biological Technology

"Over the Next 2-3 Years We Will Leverage Developmental Capabilities and Explore In-licensing and a Co-development Model to Consolidate Our Presence in Japan" - Dr. Kailash Sharma, President, Japan Operations, Zydus Cadila

TOKYO, July 30 /PRNewswire/ -- With a business plan to launch 8-10 new products each year, Nippon Universal Pharmaceutical Co. Ltd., a subsidiary of the Zydus group, one of India's leading integrated pharma companies & a global healthcare provider, is looking to give a big boost to its ope...